From: Cohort profile: King’s Health Partners bladder cancer biobank
Variable | Consented (n = 531) | % |
---|---|---|
Age (years) | 70.1 (SD: 11.6) | |
< 40 | 11 | 2.1 |
40–49 | 16 | 3.0 |
50–59 | 61 | 11.5 |
60–69 | 132 | 24.9 |
70–79 | 194 | 36.5 |
80–89 | 110 | 20.7 |
90–99 | 7 | 1.3 |
Gender | ||
Female | 112 | 21.1 |
Male | 419 | 78.9 |
Ethnicity | ||
British (White) | 302 | 56.9 |
Any other White background | 28 | 5.3 |
Mixed background | 1 | 0.2 |
Asian background | 8 | 1.5 |
Caribbean, African or Any other Black background | 9 | 1.7 |
Any other Ethnic Group | 5 | 0.9 |
Not Stated or Not Known | 178 | 22.3 |
Socioeconomic Status | ||
Low | 419 | 80.58 |
Middle | 17 | 3.27 |
High | 69 | 13.27 |
Missing | 15 | 2.88 |
Trial | ||
Yes | 32 | 6.0 |
No | 499 | 94.0 |
Comorbidities | ||
Mean number of comorbidities | 3.02 (SD:1.82) | |
Hypertension | 198 | 37.3 |
Diabetes | 89 | 16.8 |
Other cancer | 82 | 15.4 |
Hypercholesterolaemia | 80 | 15.1 |
Respiratory disease | 62 | 11.7 |
Cardiovascular disease | 62 | 11.7 |
Chronic Kidney Disease | 32 | 6.0 |
Psychiatric Disorder | 23 | 4.3 |
Smoking | ||
Yes | 183 | 34.5 |
No | 33 | 6.2 |
Unknown | 315 | 59.3 |